SNSE — Sensei Biotherapeutics, Inc.

SNSESensei Biotherapeutics, Inc.

NAS · US · Healthcare · Biotechnology · senseibio.com

17.03USD-4.24%Mkt Cap: 23.52M USDP/E: —Last update: 2026-05-26

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of th…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap23.52M USD

Enterprise Value-178.19M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-21.09M USD

Revenue/Share—

Last Price17.03 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees29

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS81728A1088

Valuation

P/E (Trailing)—

P/E (Forward)-15.68

PEG—

EV/EBITDA0.96

EV/Revenue—

P/S—

P/B1.19

EPS (TTM)-142.72

EPS (Forward)-1.12

52W Range

5.32037% of range36.76

52W High36.76 USD

52W Low5.320 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-113.41%

ROA-92.07%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-20.45M USD

CapEx (TTM)16.00K USD

FCF Margin—

FCF Yield-445.09%

Net Debt-201.75M USD

Net Debt/EBITDA1.09

Balance Sheet

Debt/Equity0.08

Current Ratio14.39

Quick Ratio14.29

Book Value/Sh14.74 USD

Cash/Share151.12 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateJun 17, 2025

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)50.00 USD

Target Range50.00 USD – 50.00 USD

# Analysts1

Ownership

Shares Out.1.34M

Float811.87K

Insiders30.15%

Institutions159.90%

Short Interest

Short Ratio19.6d

Short % Float88.51%

Short % Out.62.22%

Shares Short834.41K

Short (prev mo.)863.54K

Technical

SMA 5027.79 (-38.7%)

SMA 20015.67 (+8.7%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)31.01K

Avg Vol (10d)30.67K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—